Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alector Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ALEC
Nasdaq
8731
https://alector.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alector Inc
We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
- Dec 21st, 2022 10:01 am
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Dec 8th, 2022 9:30 pm
Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
- Nov 29th, 2022 4:05 pm
Alector Third Quarter 2022 Earnings: Misses Expectations
- Nov 10th, 2022 10:13 am
Alector (ALEC) Reports Q3 Loss, Lags Revenue Estimates
- Nov 9th, 2022 12:45 am
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
- Nov 8th, 2022 9:05 pm
Alector to Participate in Upcoming Healthcare Conferences
- Nov 7th, 2022 12:00 pm
Alector (NASDAQ:ALEC) investors are sitting on a loss of 65% if they invested a year ago
- Nov 4th, 2022 3:05 pm
Alector Announces Promotion of Clare Hunt to Chief People Officer
- Oct 13th, 2022 12:00 pm
Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)
- Sep 12th, 2022 11:00 am
Wall Street Analysts Believe Alector (ALEC) Could Rally 58%: Here's is How to Trade
- Aug 9th, 2022 1:55 pm
Alector, Inc.'s (NASDAQ:ALEC) Stock Is Going Strong: Have Financials A Role To Play?
- Aug 6th, 2022 12:33 pm
Alector (ALEC) Q2 Earnings and Revenues Beat Estimates
- Aug 4th, 2022 11:15 pm
Alector Reports Second Quarter 2022 Financial Results and Provides Business Update
- Aug 4th, 2022 8:05 pm
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
- Jul 8th, 2022 2:54 pm
Alector to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
- Jun 8th, 2022 11:00 am
Shareholders in Alector (NASDAQ:ALEC) are in the red if they invested a year ago
- May 28th, 2022 12:20 pm
Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules
- May 27th, 2022 8:30 pm
Alector (ALEC) Reports Q1 Loss, Misses Revenue Estimates
- May 5th, 2022 10:25 pm
Alector Reports First Quarter 2022 Financial Results and Provides Business Update
- May 5th, 2022 8:05 pm
Scroll